Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AARP Supports Canadian Imports To Place “Downward Pressure” On Rx Costs

Executive Summary

AARP is endorsing prescription drug reimportation from Canada as a measure to help control the cost of drugs

You may also be interested in...



Schering Sees No Impact From Imports; Not Attractive To “Parallel Traders”

Schering-Plough sees one advantage to operating as a smaller pharmaceutical player: little or no impact from a potential U.S.-sanctioned drug importation policy

Schering Sees No Impact From Imports; Not Attractive To “Parallel Traders”

Schering-Plough sees one advantage to operating as a smaller pharmaceutical player: little or no impact from a potential U.S.-sanctioned drug importation policy

AARP Wants HHS Price Negotiation If Medicare Discounts Are Insufficient

AARP would work to give HHS negotiating authority on Medicare drug prices if discounts negotiated by private plans and manufacturers are inadequate

Related Content

UsernamePublicRestriction

Register

ID1132090

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel